Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Kim, Mee Ohk ^a   Cali, Ignazio ^b,c   Oehler, Abby ^d   Fong, Jamie C ^a   Wong, Katherine ^a   See, Tricia ^a   Katz, Jonathan S ^e   Gambetti, Pierluigi ^b   Bettcher, Brianne M ^a   DeArmond, Stephen J ^d   Geschwind, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Creutzfeldt Jakob disease; Curvilinear PrPSc; E200K; Familial CJD; Synaptic PrPSc

Indexed keywords

EID: 85005896404     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-1-80     Document Type: Article

References (50)

1. Kong Q, Surewicz WK, Petersen RB, et al.: Inherited prion diseases. In Prion Biology and Diseases. 2nd edition. Edited by: Prusiner SB. City: Cold Spring Harbor Laboratory Press; 2004:673-775.
2. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG: Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003, 66: 213-239. 10.1093/bmb/66.1.213
3. Goldgaber D, Goldfarb LG, Brown P, et al.: Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker's syndrome. Exp Neurol 1989, 106: 204-206. 10.1016/0014-4886(89)90095-2
4. Lee HS, Sambuughin N, Cervenakova L, et al.: Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. Am J Hum Genet 1999, 64: 1063-1070. 10.1086/302340
5. Korczyn AD, Chapman J, Goldfarb LG, Brown P, Gajdusek DC: A mutation in the prion protein gene in Creutzfeldt-Jakob disease in Jewish patients of Libyan, Greek, and Tunisian origin. Ann N Y Acad Sci 1991, 640: 171-176.
6. Kovacs GG, Puopolo M, Ladogana A, et al.: Genetic prion disease: the EUROCJD experience. Hum Genet 2005, 118: 166-174. 10.1007/s00439-005-0020-1
7. Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H: Mutations of the prion protein gene phenotypic spectrum. J Neurol 2002, 249: 1567-1582. 10.1007/s00415-002-0896-9
8. Mitrova E, Belay G: Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 2002, 46: 31-39.
9. Hsiao K, Meiner Z, Kahana E, et al.: Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 1991, 324: 1091-1097. 10.1056/NEJM199104183241604
10. Meiner Z, Gabizon R, Prusiner SB: Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews. Medicine (Baltimore) 1997, 76: 227-237. 10.1097/00005792-199707000-00001
11. Ghetti B, Piccardo P, Spillantini MG, et al.: Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 1996, 93: 744-748. 10.1073/pnas.93.2.744
12. Debatin L, Streffer J, Geissen M, Matschke J, Aguzzi A, Glatzel M: Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener Dis 2008, 5: 347-354. doi: 10.1159/000121389 10.1159/000121389
13. Ghoshal N, Cali I, Perrin RJ, et al.: Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype. Arch Neurol 2009, 66: 1240-1246.
14. Kovacs GG, Seguin J, I Q, et al.: Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol 2011, 121: 39-57. doi: 10.1007/s00401-010-0713-y 10.1007/s00401-010-0713-y
15. Vital A, Fernagut PO, Canron MH, et al.: The nigrostriatal pathway in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 2009, 68: 809-815. doi: 10.1097/NEN.0b013e3181abdae8 10.1097/NEN.0b013e3181abdae8
16. Carswell C, Thompson A, A L, et al.: MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol 2012, 12: 153. doi: 10.1186/1471-2377-12-153 10.1186/1471-2377-12-153
17. Puoti G, Rossi G, G G, et al.: Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt-Jakob disease linked to E200K mutation. Ann Neurol 2000, 48: 269-270.
18. Geschwind MD, Potter CA, Sattavat M, et al.: Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease. Alzheimer Dis Assoc Disord 2009, 23: 82-87. 10.1097/WAD.0b013e31818323ef
19. Safar JG, Geschwind MD, Deering C, et al.: Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005, 102: 3501-3506. 10.1073/pnas.0409651102
20. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J: Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996, 53: 913-920. 10.1001/archneur.1996.00550090125018
21. Gundersen HJ, Jensen EB, Kieu K, Nielsen J: The efficiency of systematic sampling in stereology-reconsidered. J Microsc 1999, 193: 199-211. 10.1046/j.1365-2818.1999.00457.x
22. Parchi P, Giese A, Capellari S, et al.: Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999, 46: 224-233. 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W
23. Cali I, Castellani R, J Y, et al.: Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 2006, 129: 2266-2277. 10.1093/brain/awl224
24. Kascsak RJ, Rubenstein R, Merz PA, et al.: Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987, 61: 3688-3693.
25. Tartaglia MC, Sidhu M, V L, et al.: Sporadic corticobasal syndrome due to FTLD-TDP. Acta Neuropathol 2010, 119: 365-374. doi: 10.1007/s00401-009-0605-1 10.1007/s00401-009-0605-1
26. Kovacs GG, Molnar K, Keller E, Botond G, Budka H, Laszlo L: Intraneuronal immunoreactivity for the prion protein distinguishes a subset of E200K genetic from sporadic Creutzfeldt-Jakob Disease. J Neuropathol Exp Neurol 2012, 71: 223-232. doi: 10.1097/NEN.0b013e318248aa70 10.1097/NEN.0b013e318248aa70
27. Monari L, Chen SG, P B, et al.: Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994, 91: 2839-2842. 10.1073/pnas.91.7.2839
28. Parchi P, Capellari S, Chen SG: Typing prion isoforms. Nature 1997, 386: 232-234. 10.1038/386232a0
29. Hainfellner JA, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H: A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 1999, 45: 812-816. 10.1002/1531-8249(199906)45:6<812::AID-ANA20>3.0.CO;2-2
30. Geschwind MD, Kuryan C, Cattaruzza T, Vitali P, DeArmond S, Wong K: Brain MRI in sporadic Jakob-Creutzfeldt disease is often misread. Neurology 2010, 78: P03.018.
31. Appel SA, Chapman J, Prohovnik I, Hoffman C, Cohen OS, Blatt I: The EEG in E200K familial CJD: relation to MRI patterns. J Neurol 2012, 259: 491-496. doi: 10.1007/s00415-011-6208-5 10.1007/s00415-011-6208-5
32. Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I: MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008, 29: 1638-1643. 10.3174/ajnr.A1217
33. Brown P, Goldfarb LG, Gibbs CJ Jr, Gajdusek DC: The phenotypic expression of different mutations in transmissible familial Creutzfeldt-Jakob disease. Eur J Epidemiol 1991, 7: 469-476. 10.1007/BF00143124
34. Brown P, Cathala F, Castaigne P, Gajdusek DC: Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986, 20: 597-602. 10.1002/ana.410200507
35. Jarius C, Kovacs GG, Belay G, Hainfellner JA, Mitrova E, Budka H: Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease. Acta Neuropathol 2003, 105: 449-454. doi: 10.1007/s00401-002-0664-z
36. Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P: Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 2011, 121: 21-37. 10.1007/s00401-010-0760-4
37. Taratuto AL, Piccardo P, Reich EG: Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. Neurology 2002, 58: 362-367. 10.1212/WNL.58.3.362
38. Medori R, Tritschler HJ, A LB, et al.: Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992, 326: 444-449. doi: 10.1056/NEJM199202133260704 10.1056/NEJM199202133260704
39. Parchi P, Capellari S, S C, et al.: A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999, 52: 1757-1763. 10.1212/WNL.52.9.1757
40. Elobeid A, Soininen H, Alafuzoff I: Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 2012, 123: 97-104. doi: 10.1007/s00401-011-0906-z 10.1007/s00401-011-0906-z
41. Kitamoto T, Shin RW, K D-u: Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992, 140: 1285-1294.
42. Fraser H: Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway. Nature 1982, 295: 149-150. 10.1038/295149a0
43. Scott JR, Davies D, Fraser H: Scrapie in the central nervous system: neuroanatomical spread of infection and Sinc control of pathogenesis. J Gen Virol 1992,73(Pt 7):1637-1644.
44. Beekes M, McBride PA, Baldauf E: Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J Gen Virol 1998,79(Pt 3):601-607.
45. Bouzamondo-Bernstein E, Hopkins SD, P S, et al.: The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol 2004, 63: 882-899.
46. Gardner RC, Boxer AL, A T, et al.: Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol 2013. doi: 10.1002/ana.23844
47. Frost B, Ollesch J, Wille H, Diamond MI: Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J Biol Chem 2009, 284: 3546-3551.
48. Frost B, Jacks RL, Diamond MI: Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009, 284: 12845-12852. 10.1074/jbc.M808759200
49. Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI: Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem 2012, 287: 19440-19451. doi: 10.1074/jbc.M112.346072 10.1074/jbc.M112.346072
50. Friedman-Levi Y, Meiner Z, Canello T, et al.: Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease. PLoS Pathog 2011, 7: e1002350. doi: 10.1371/journal.ppat.1002350 PPATHOGENS-D-11-01077 10.1371/journal.ppat.1002350